Establishment Labs Holdings Inc. $ESTA Position Increased by Sigma Planning Corp

Sigma Planning Corp grew its position in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 325.5% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 20,424 shares of the company’s stock after purchasing an additional 15,624 shares during the period. Sigma Planning Corp’s holdings in Establishment Labs were worth $1,160,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Quarry LP purchased a new position in shares of Establishment Labs in the third quarter worth approximately $34,000. Kestra Advisory Services LLC acquired a new position in Establishment Labs in the 4th quarter worth approximately $47,000. Osaic Holdings Inc. boosted its stake in Establishment Labs by 900.0% in the 2nd quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock worth $85,000 after purchasing an additional 1,800 shares during the period. MV Capital Management Inc. purchased a new position in Establishment Labs during the 4th quarter worth approximately $146,000. Finally, Truist Financial Corp purchased a new position in Establishment Labs during the 4th quarter worth approximately $200,000. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Establishment Labs

In related news, Director Quiros Juan Jose Chacon sold 105,000 shares of the stock in a transaction on Wednesday, May 6th. The stock was sold at an average price of $75.42, for a total transaction of $7,919,100.00. Following the completion of the sale, the director directly owned 927,504 shares in the company, valued at approximately $69,952,351.68. This trade represents a 10.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold 255,000 shares of company stock valued at $18,144,896 over the last 90 days. Corporate insiders own 9.99% of the company’s stock.

Establishment Labs Stock Performance

Shares of ESTA opened at $92.58 on Friday. The company has a market capitalization of $2.72 billion, a PE ratio of -62.13 and a beta of 1.06. The company has a debt-to-equity ratio of 16.82, a quick ratio of 1.91 and a current ratio of 2.96. The company’s 50 day moving average price is $80.16 and its 200 day moving average price is $71.98. Establishment Labs Holdings Inc. has a 52 week low of $33.35 and a 52 week high of $93.12.

Establishment Labs (NASDAQ:ESTA) last released its earnings results on Thursday, May 7th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.10). The company had revenue of $59.88 million during the quarter, compared to analysts’ expectations of $57.40 million. Establishment Labs had a negative return on equity of 218.77% and a negative net margin of 19.05%.The firm’s quarterly revenue was up 44.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.70) EPS. Research analysts expect that Establishment Labs Holdings Inc. will post -1.07 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ESTA. Wall Street Zen downgraded shares of Establishment Labs from a “buy” rating to a “hold” rating in a research note on Saturday, March 28th. BTIG Research reaffirmed a “buy” rating on shares of Establishment Labs in a research report on Monday, July 13th. Mizuho lifted their price target on Establishment Labs from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday. Citigroup upped their price target on Establishment Labs from $76.00 to $92.00 and gave the company a “neutral” rating in a research report on Wednesday, July 8th. Finally, TD Cowen reissued a “buy” rating on shares of Establishment Labs in a research note on Monday, June 8th. Seven research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $90.43.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.